Wesseling P - Search Results

1

WHO 2016 Classification of gliomas.

Wesseling P, Capper D. Wesseling P, et al. Neuropathol Appl Neurobiol. 2018 Feb;44(2):139-150. doi: 10.1111/nan.12432. Neuropathol Appl Neurobiol. 2018. PMID: 28815663 Review.

2

Conventional radiotherapy combined with carbogen breathing and nicotinamide for malignant gliomas.

van der Maazen RW, Thijssen HO, Kaanders JH, de Koster A, Keyser A, Prick MJ, Grotenhuis JA, Wesseling P, van der Kogel AJ. van der Maazen RW, et al. Among authors: wesseling p. Radiother Oncol. 1995 May;35(2):118-22. doi: 10.1016/0167-8140(95)01534-n. Radiother Oncol. 1995. PMID: 7569019 Free article.

3

A uniform histological cluster scheme for ICD-O-coded primary central nervous system tumors.

van der Sanden GA, Wesseling P, Schouten LJ, Teepen HL, Coebergh J. van der Sanden GA, et al. Among authors: wesseling p. Neuroepidemiology. 1998;17(5):233-46. doi: 10.1159/000026176. Neuroepidemiology. 1998. PMID: 9705583

4

Differential patterns of insulin-like growth factor-I and -II mRNA expression in medulloblastoma.

van Doorn J, Gilhuis HJ, Koster JG, Wesseling P, Reddingius RE, Gresnigt MG, Bloemen RJ, van Muijen GN, van Buul-Offers SC. van Doorn J, et al. Among authors: wesseling p. Neuropathol Appl Neurobiol. 2004 Oct;30(5):503-12. doi: 10.1111/j.1365-2990.2004.00571.x. Neuropathol Appl Neurobiol. 2004. PMID: 15488026

5

Molecular pathogenesis of oligodendroglial tumors.

Jeuken JW, von Deimling A, Wesseling P. Jeuken JW, et al. Among authors: wesseling p. J Neurooncol. 2004 Nov;70(2):161-81. doi: 10.1007/s11060-004-2748-1. J Neurooncol. 2004. PMID: 15674476 Review.

6

Specific association of small heat shock proteins with the pathological hallmarks of Alzheimer's disease brains.

Wilhelmus MM, Otte-Höller I, Wesseling P, de Waal RM, Boelens WC, Verbeek MM. Wilhelmus MM, et al. Among authors: wesseling p. Neuropathol Appl Neurobiol. 2006 Apr;32(2):119-30. doi: 10.1111/j.1365-2990.2006.00689.x. Neuropathol Appl Neurobiol. 2006. PMID: 16599941

7

CD4+FoxP3+ regulatory T cells gradually accumulate in gliomas during tumor growth and efficiently suppress antiglioma immune responses in vivo.

Grauer OM, Nierkens S, Bennink E, Toonen LW, Boon L, Wesseling P, Sutmuller RP, Adema GJ. Grauer OM, et al. Among authors: wesseling p. Int J Cancer. 2007 Jul 1;121(1):95-105. doi: 10.1002/ijc.22607. Int J Cancer. 2007. PMID: 17315190 Free article.

8

Immunotherapy of diffuse gliomas: helping the brain fight back!

Wesseling P, Adema GJ. Wesseling P, et al. Brain Pathol. 2009 Oct;19(4):672-3. doi: 10.1111/j.1750-3639.2009.00317.x. Brain Pathol. 2009. PMID: 19744039 Free PMC article. No abstract available.

9

Immunotherapy of diffuse gliomas: biological background, current status and future developments.

Grauer OM, Wesseling P, Adema GJ. Grauer OM, et al. Among authors: wesseling p. Brain Pathol. 2009 Oct;19(4):674-93. doi: 10.1111/j.1750-3639.2009.00315.x. Brain Pathol. 2009. PMID: 19744040 Free PMC article. Review.

10

Molecular diagnostics of gliomas: state of the art.

Riemenschneider MJ, Jeuken JW, Wesseling P, Reifenberger G. Riemenschneider MJ, et al. Among authors: wesseling p. Acta Neuropathol. 2010 Nov;120(5):567-84. doi: 10.1007/s00401-010-0736-4. Epub 2010 Aug 17. Acta Neuropathol. 2010. PMID: 20714900 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results